E-LIB Suche - Ergebnisse für: Karlin, Lionel

1

Teclistamab Improves Patient-Reported Symptoms and Health-R..:

Martin, Thomas G. ; Moreau, Philippe ; Usmani, Saad Z....
Clinical Lymphoma Myeloma and Leukemia. 24 (2024) 3 - p. 194-202 , 2024

Link: https://doi.org/10.1016/..

2

Characteristics and incidence of infections in patients wit..:

Jourdes, Aurélie ; Cellerin, Elise ; Touzeau, Cyrille...
Clinical Microbiology and Infection. 30 (2024) 6 - p. 764-771 , 2024

Link: https://doi.org/10.1016/..

3

Efficacy and Safety in Patients with Lenalidomide-Refractor..:

Sidiqi, M Hasib ; Corradini, Paolo ; Purtill, Duncan...
Transplantation and Cellular Therapy. 30 (2024) 2 - p. S376 , 2024

Link: https://doi.org/10.1016/..

4

Teclistamab in relapsed or refractory AL amyloidosis: a mul..:

Forgeard, Nathalie ; Elessa, Dikélélé ; Carpinteiro, Alexander...
Blood. 143 (2024) 8 - p. 734-737 , 2024

Link: https://doi.org/10.1182/..

5

Comparative Efficacy of Talquetamab vs. Current Treatments ..:

Einsele, Hermann ; Moreau, Philippe ; Bahlis, Nizar...
Advances in Therapy. 41 (2024) 4 - p. 1576-1593 , 2024

Link: https://doi.org/10.1007/..

6

Isatuximab plus pomalidomide and dexamethasone in patients ..:

Decaux, Olivier ; Fontan, Jean ; Perrot, Aurore...
European Journal of Haematology. , 2024

Link: https://doi.org/10.1111/..

7

Daratumumab, carfilzomib, lenalidomide, and dexamethasone w..:

Touzeau, Cyrille ; Perrot, Aurore ; Hulin, Cyrille...
Blood. 143 (2024) 20 - p. 2029-2036 , 2024

Link: https://doi.org/10.1182/..

8

P923: COMPARATIVE EFFECTIVENESS OF TALQUETAMAB VS REAL-WORL..:

Einsele, Hermann ; Moreau, Philippe ; Bahlis, Nizar J...
HemaSphere. 7 (2023) S3 - p. e5183528 , 2023

Link: https://doi.org/10.1097/..

9

Daratumumab, carfilzomib, and dexamethasone in relapsed or ..:

Moreau, Philippe ; Chari, Ajai ; Oriol, Albert...
Blood Cancer Journal. 13 (2023) 1 - p. , 2023

Link: https://doi.org/10.1038/..

10

POSTER: MM-374 Efficacy and Safety of Elranatamab in Patien..:

Nooka, Ajay K. ; Lesokhin, Alexander M. ; Mohty, Mohamad...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S219 , 2023

Link: https://doi.org/10.1016/..

11

P-302 Anchor (OP-104): melflufen plus dexamethasone and dar..:

Ocio, Enrique ; Efebera, Yvonne ; Hájek, Roman...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S204 , 2023

Link: https://doi.org/10.1016/..

12

MM-374 Efficacy and Safety of Elranatamab in Patients With ..:

Nooka, Ajay K. ; Lesokhin, Alexander M. ; Mohty, Mohamad...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S496-S497 , 2023

Link: https://doi.org/10.1016/..

13

Comparative Efficacy of Teclistamab Versus Current Treatmen..:

Moreau, Philippe ; van de Donk, Niels W. C. J. ; Delforge, Michel...
Advances in Therapy. 40 (2023) 5 - p. 2412-2425 , 2023

Link: https://doi.org/10.1007/..

14

P-325 Standard of care (SOC) outcomes in the last 3 years i..:

Weisel, Katja ; Mateos, Maria-Victoria ; Garcia, Maria Esther Gonzalez...
Clinical Lymphoma Myeloma and Leukemia. 23 (2023) - p. S217-S218 , 2023

Link: https://doi.org/10.1016/..

15

Pomalidomide and dexamethasone until progression after firs..:

Garderet, Laurent ; Kuhnowski, Frederique ; Berge, Benoit...
British Journal of Haematology. 201 (2023) 6 - p. 1103-1115 , 2023

Link: https://doi.org/10.1111/..